Cibc World Market Inc. lifted its position in Albemarle Corporation (NYSE:ALB – Free Report) by 715.6% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 186,408 shares of the specialty chemicals company’s stock after acquiring an additional 163,553 shares during the quarter. Cibc World Market Inc.’s holdings in Albemarle were worth $19,718,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently modified their holdings of the business. Ethic Inc. grew its holdings in shares of Albemarle by 233.0% during the 3rd quarter. Ethic Inc. now owns 71,694 shares of the specialty chemicals company’s stock worth $7,584,000 after acquiring an additional 50,167 shares during the period. AEGON ASSET MANAGEMENT UK Plc lifted its stake in shares of Albemarle by 5,070.9% in the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 85,579 shares of the specialty chemicals company’s stock valued at $9,053,000 after purchasing an additional 83,924 shares during the period. Wellington Management Group LLP lifted its stake in shares of Albemarle by 161.8% in the 2nd quarter. Wellington Management Group LLP now owns 49,412 shares of the specialty chemicals company’s stock valued at $6,672,000 after purchasing an additional 30,541 shares during the period. Great Lakes Advisors LLC purchased a new position in shares of Albemarle in the 2nd quarter valued at approximately $4,246,000. Finally, WINTON GROUP Ltd bought a new stake in shares of Albemarle during the second quarter valued at approximately $4,145,000. 92.87% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. BMO Capital Markets decreased their price target on shares of Albemarle from $200.00 to $175.00 and set an “outperform” rating for the company in a research note on Tuesday, October 6th. Citigroup boosted their price objective on shares of Albemarle from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, November 9th. Barclays cut their price objective on shares of Albemarle from $109.00 to $95.00 and set an “equal weight” rating on the stock in a report on Friday, November 6th. Bank of America decreased their target price on shares of Albemarle from $131.00 to $120.00 in a research note on Thursday, November 12th. Finally, Truist Financial reiterated a “buy” rating and set a $170.00 target price (down from $185.00) on shares of Albemarle in a report on Friday, November 6th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $152.63.
Check Out Our Latest Analysis on ALB
Albemarle Price Performance
ALB opened at $85.64 on Thursday. The firm has a market cap of $10.11 billion, a PE ratio of 20.69, a P/E/G ratio of 0.55 and a beta of 1.34. The stock has a 50-day moving average price of $101.19 and a 200-day moving average price of $144.19. Albemarle Corporation has a 1 year low of $85.22 and a 1 year high of $221.00. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.34 and a quick ratio of 1.57.
Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.05. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.52 billion. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. Albemarle’s revenue was up 18.8% compared to the same quarter last year. During the same period last year, the business earned ($0.19) EPS. Sell-side analysts predict that Albemarle Corporation will post 10.64 earnings per share for the current fiscal year.
Albemarle Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be issued a $0.41 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.9%. Albemarle’s dividend payout ratio (DPR) is presently 39.61%.
About Albemarle
Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.
Further Reading
- Five stocks we like better than Albemarle
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
